A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Active, not recruiting · NCT03467867 · Registry updated 2026-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-04-06 | NCT03467867 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Georgetown University | 73 |
| Hackensack Meridian Health | 52 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Georgetown University Medical Center | Washington D.C. | United States | 62 |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | United States | 37 |